USPTO issues patent to MicuRx’s MRX-I antibacterial agent : MicuRx Pharmaceuticals, Inc., a privately-held biopharmaceutical company devel...

Erivedge(vismodegib) has been approved by the U.S. Food and Drug Administration to treat the most common form of skin cancer, basal cel...